IP Verse

Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine - EP1731152

The patent EP1731152 was granted to Euro Celtique on May 1, 2013. The application was originally filed on Feb 24, 1998 under application number EP06118876A. The patent is currently recorded with a legal status of "Revoked".

EP1731152

EURO CELTIQUE
Application Number
EP06118876A
Filing Date
Feb 24, 1998
Status
Revoked
Feb 17, 2020
Grant Date
May 1, 2013
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TESA LABTECDec 20, 2017BIRD & BIRDINTERVENTION
GALLAFENTJan 24, 2014BIRD & BIRDADMISSIBLE
HEXALJan 23, 2014TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONUS4806341
EXAMINATIONUS5069909
EXAMINATIONUS5225199
OPPOSITIONDE4237453
OPPOSITIONUS4588580
OPPOSITIONUS4938759
OPPOSITIONUS4956171
OPPOSITIONUS5026556
OPPOSITIONUS5069909
OPPOSITIONUS5171576
OPPOSITIONUS5225199
OPPOSITIONUS5240711
OPPOSITIONWO2012065740
OPPOSITIONWO9619975
OPPOSITIONWO9836728
SEARCHUS4588580
SEARCHUS4956171
SEARCHUS5026556
SEARCHUS5240711
SEARCHUS5486362
SEARCHWO9619975

Non-Patent Literature (NPL) Citations (22) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- ROY S.D. ET AL., "Transdermal delivery of buprenorphine through cadaver skin", JOURNAL OF PHARMACEUTICAL SCIENCES, (199402), vol. 83, no. 2, pages 126 - 130-
OPPOSITION- "Chapter 10", H.C. ANSEL et al., Pharmaceutical Dosage Forms and Drug delivery Systems, WILLIAMS & WILKINS, (19950000), pages 357 - 372, XP055449922-
OPPOSITION- "Chapter 3", Hadgraft J. et al, Transdermal Drug Delivery, Marcel Dekker, (19890000), pages 59 - 81, XP055449896-
OPPOSITION- EMC, "BuTrans 5, 10 and 20µg/h Transdermal Patch", Summary of Product Characteristics, (20100311), URL: http://www.medicines.org.uk/EMC, XP003035774-
OPPOSITION- Falbe J. et al, Römpp Chemie Lexikon, Georg Thieme Verlag, (19910000), page 3095, XP055449956-
OPPOSITION- J.J. KUHLMAN et al., "Human Pharmacokinetics of Intravenous, Sublingual, and Buccal Buprenorphine", Journal of Analytical Toxicology, (19961001), vol. 20, no. 6, pages 369 - 378, XP008114619-
OPPOSITION- K. HEILMANN, Therapeutische Systeme, Stuttgart, Ferdinand Enke Verlag, (19840000), pages 104 - 106, XP055449913-
OPPOSITION- K. HEILMANN, Therapeutische Systeme, Stuttgart, Ferdinand Enke Verlag, (19840000), pages 26 - 27 , 48-53-
OPPOSITION- K. HEILMANN, Therapeutische Systeme, Stuttgart, Ferdinand Enke Verlag, (19840000), pages 67 - 77 , 83-86, XP055449911-
OPPOSITION- S. KIYOSHI et al., "Species Differences in Percutaneous Absorption of Nicorandil", Journal of Pharmaceutical Sciences, (19910200), vol. 80, no. 2, pages 104 - 107, XP055449853
OPPOSITION- S.D. ROY et al., "TRANSDERMAL DELIVERY OF BUPRENORPHINE THROUGH CADAVER SKIN", Journal of Pharmaceutical Sciences, (19940000), vol. 83, no. 2, pages 126 - 130, XP009079712
OPPOSITION- S.D. ROY et al., "Transdermal Delivery of Narcotic Analgesics: Comparative Metabolism and Permeability of Human Cadaver Skin and Hairless Mouse Skin", Journal of Pharmaceutical Sciences, (19940318), vol. 83, no. 12, pages 1723 - 1728, XP055449928
OPPOSITION- S.F. GORDON, "Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy", Am J Obstet Gynecol, (19950000), vol. 173, no. 3 Part 2, pages 998 - 1004, XP002953772
OPPOSITION- A. GÖPFERICH et al., "An improved diffusion/ compartmental model for transdermal drug delivery from a matrix-type device", International Journal of Pharmaceutics, (19910000), vol. 71, no. 3, pages 237 - 243, XP025580080
OPPOSITION- WILDING et al., "Pharmacokinetic evaluation of transdermal buprenorphine in man", International Journal of Pharmaceutics, (19960400), vol. 132, no. 1-2, pages 81 - 87, XP055449841
OPPOSITION- Guy R. H., "Current Status and Future Prospects of Transdermal Drug Delivery", Pharmaceutical Research, (19961200), vol. 13, no. 12, pages 1765 - 1769, XP009081195
OPPOSITION- Margetts L. et al, "Transdermal drug delivery: principles and opioid therapy", Continuing Education in Anaesthesia, Critical Care and Pain, (20071001), vol. 7, no. 5, pages 171 - 176, XP055395614
OPPOSITION- K. WALTER et al., "Pharmacokinetics of physostigmine in man following a single application of a transdermal system", Br J clin Pharmac, (19950100), vol. 39, pages 59 - 63, XP055449846
OPPOSITION- T. KAKUJI et al., "Stratum Corneum Reservoir Capacity Affecting Dynamics of Transdermal Drug Delivery", Drug Development and Industrial Pharmacy, (19880000), vol. 14, no. 4, pages 561 - 572, XP055449849
SEARCH- FRIEND D ET AL, "TRANSDERMAL DELIVERY OF LEVONORGESTREL I: ALKANOLS AS PERMEATION ENHANCERS IN VITRO", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (19880901), vol. 7, no. 3, ISSN 0168-3659, pages 243 - 250, XP000566313 [Y] 1-11 * figures 2,3 *
SEARCH- FRIEND D ET AL, "SIMPLE ALKYL ESTERS AS SKIN PERMEATION ENHANCERS", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (19890601), vol. 9, no. 1, ISSN 0168-3659, pages 33 - 41, XP000007883 [Y] 1-11 * figures 11,12 *
SEARCH- ROY S D ET AL, "CONTROLLED TRANSDERMAL DELIVERY OF FENTANYL: CHARACTERIZATIONS OF PRESSURE-SENSITIVE ADHESIVES FOR MATRIX PATCH DESIGN", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION. WASHINGTON, US, (19960501), vol. 85, no. 5, ISSN 0022-3549, pages 491 - 495, XP000583527 [Y] 1-11 * figure 5 * * page 495, second paragraph *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents